鐢�(ch菐n)鍝佸悕绋�(ch膿ng) | BTB/POZ绲�(ji茅)妲�(g貌u)鍩熻泲鐧�7鎶楅珨 |
鑻辨枃鍚嶇ū(ch膿ng) | Anti-BTBD7 |
瑕�(gu墨)鏍� | 0.2ml/200渭g |
婵冨害 | 1mg/1ml |
鍍�(ji脿)鏍� | 渚�(l谩i)闆诲彲浜彈鍎�(y艒u)鎯� |
鑻辨枃鍚嶇ū(ch膿ng) Anti-BTBD7
涓枃鍚嶇ū(ch膿ng) BTB/POZ绲�(ji茅)妲�(g貌u)鍩熻泲鐧�7鎶楅珨
婵� 搴� 1mg/1ml
瑕�(gu墨) 鏍� 0.2ml/200渭g
鎶楅珨渚�(l谩i)婧� Rabbit
鍏嬮殕椤�(l猫i)鍨� polyclonal
浜ゅ弶鍙嶆噳(y墨ng) Human, Mouse, Rat, Dog, Pig, Cow, Horse, Sheep
鐢�(ch菐n)鍝侀(l猫i)鍨� 涓€鎶�
鐮旂┒闋�(l菒ng)鍩� 鑵槫 绱�(x矛)鑳炵敓鐗� 杞�(zhu菐n)閷勮(di脿o)绡€(ji茅)鍥犲瓙
铔嬬櫧鍒嗗瓙閲� predicted molecular weight: 126kDa
鎬� 鐙€ Lyophilized or Liquid
鍏� 鐤� 鍘� KLH conjugated synthetic peptide derived from humanBTBD7
浜� 鍨� IgG
绱斿寲鏂规硶 affinity purified by Protein A
鍎�(ch菙) 瀛� 娑� Preservative: 15mM Sodium Azide, Constituents: 1%BSA, 0.01M PBS, pH 7.4
鐢�(ch菐n)鍝佹噳(y墨ng)鐢� WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
锛堢煶锠熷垏鐗囬渶鍋氭姉鍘熶慨寰�(f霉)锛�
not yet tested in other applications.
optimal dilutions/concentrations should be determined by theend user.
淇濆瓨姊濅欢 Store at -85 掳C for oneyear.
鍒� 鍚� BTB/POZ domain-containing protein 7; BTBD7;BTBD7_HUMAN; FUP1; KIAA1525; 8030448M07; E130118E17Rik; mKIAA1525;5730507E09Rik.
